Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.

BACKGROUND: Reducing bisphosphonate dosing frequency may improve suboptimal adherence to treatment and therefore therapeutic outcomes in postmenopausal osteoporosis. Once-monthly oral ibandronate has been developed to overcome this problem. OBJECTIVE: To confirm the 1 year results and provide more e...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Reginster, J, Adami, S, Lakatos, P, Greenwald, M, Stepan, J, Silverman, S, Christiansen, C, Rowell, L, Mairon, N, Bonvoisin, B, Drezner, M, Emkey, R, Felsenberg, D, Cooper, C, Delmas, P, Miller, P
Materiálatiipa: Journal article
Giella:English
Almmustuhtton: 2006

Geahča maid